公司資料
OncoMed Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- OMED
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
目前無法取得 OMED 的收盤價變動背景。
公司概覽
業務概覽
OncoMed was an oncology company focused on cancer stem cells and targeted cancer biology before its restructuring and decline. Its work centered on early immuno-oncology and tumor biology.
所在地與產業分類
Headquartered in the United States and formerly listed on NASDAQ, OncoMed sat in oncology biotechnology.
商業模式特徵
The company depended on clinical development, platform validation, and strategic progress.
生技產業定位
OncoMed belongs to the historical oncology-biotech category rather than the current live public-company set.
未來催化劑
- OncoMed is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update. There is no broad live pipeline driving the name.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。